Tag: Pemigatinib

First receiving accelerated approval from the FDA in 2020 for certain bile duct cancers, the specialized targeted therapy Pemazyre prompts the question: **Who is the manufacturer of pemigatinib?** The answer is Incyte Corporation, a global biopharmaceutical company focusing on the discovery, development, and commercialization of proprietary therapeutics.

The imprint on a pill is a crucial identifier, yet a single marking can sometimes correspond to more than one medication, differing in shape and purpose. The 'I 9' pill is a prime example, with two vastly different drugs bearing this mark. Proper identification of the pill's complete appearance is essential to determine what the i-9 pill is used for.

According to reports, medication mix-ups are a common safety concern, underscoring the importance of verifying pills before consumption. For those wondering **what is an I9 pill used for?**, the answer is not simple, as the imprint is associated with two completely different medications with distinct physical appearances, mechanisms of action, and uses.